645 related articles for article (PubMed ID: 17520685)
1. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry in the characterization of human genetic N-glycosylation defects.
Barone R; Sturiale L; Garozzo D
Mass Spectrom Rev; 2009; 28(3):517-42. PubMed ID: 18844296
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry for congenital disorders of glycosylation, CDG.
Wada Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
[TBL] [Abstract][Full Text] [Related]
4. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation.
Foulquier F; Ungar D; Reynders E; Zeevaert R; Mills P; García-Silva MT; Briones P; Winchester B; Morelle W; Krieger M; Annaert W; Matthijs G
Hum Mol Genet; 2007 Apr; 16(7):717-30. PubMed ID: 17220172
[TBL] [Abstract][Full Text] [Related]
5. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis.
Butler M; Quelhas D; Critchley AJ; Carchon H; Hebestreit HF; Hibbert RG; Vilarinho L; Teles E; Matthijs G; Schollen E; Argibay P; Harvey DJ; Dwek RA; Jaeken J; Rudd PM
Glycobiology; 2003 Sep; 13(9):601-22. PubMed ID: 12773475
[TBL] [Abstract][Full Text] [Related]
6. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
[TBL] [Abstract][Full Text] [Related]
7. Analysis of protein glycosylation by mass spectrometry.
Morelle W; Michalski JC
Nat Protoc; 2007; 2(7):1585-602. PubMed ID: 17585300
[TBL] [Abstract][Full Text] [Related]
8. Integrated mass spectrometric strategy for characterizing the glycans from glycosphingolipids and glycoproteins: direct identification of sialyl Le(x) in mice.
Parry S; Ledger V; Tissot B; Haslam SM; Scott J; Morris HR; Dell A
Glycobiology; 2007 Jun; 17(6):646-54. PubMed ID: 17341505
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
10. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.
Morelle W; Faid V; Chirat F; Michalski JC
Methods Mol Biol; 2009; 534():5-21. PubMed ID: 19277556
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Sturiale L; Barone R; Fiumara A; Perez M; Zaffanello M; Sorge G; Pavone L; Tortorelli S; O'Brien JF; Jaeken J; Garozzo D
Glycobiology; 2005 Dec; 15(12):1268-76. PubMed ID: 16037488
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical features in a Congolese infant with congenital disorder of glycosylation (CDG)-IIx.
Nsibu NC; Jaeken J; Carchon H; Mampunza M; Sturiale L; Garozzo D; Mashako MN; Tshibassu MP
Eur J Paediatr Neurol; 2008 May; 12(3):257-61. PubMed ID: 17884642
[TBL] [Abstract][Full Text] [Related]
13. Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry.
Morelle W; Donadio S; Ronin C; Michalski JC
Rapid Commun Mass Spectrom; 2006; 20(3):331-45. PubMed ID: 16372382
[TBL] [Abstract][Full Text] [Related]
14. Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI-TOF MS.
Sturiale L; Barone R; Palmigiano A; Ndosimao CN; Briones P; Adamowicz M; Jaeken J; Garozzo D
Proteomics; 2008 Sep; 8(18):3822-32. PubMed ID: 18712764
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteomics of N-glycosylation by in-gel deglycosylation and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry mapping: application to congenital disorders of glycosylation.
Sagi D; Kienz P; Denecke J; Marquardt T; Peter-Katalinić J
Proteomics; 2005 Jul; 5(10):2689-701. PubMed ID: 15912511
[TBL] [Abstract][Full Text] [Related]
16. Altered glycan structures: the molecular basis of congenital disorders of glycosylation.
Freeze HH; Aebi M
Curr Opin Struct Biol; 2005 Oct; 15(5):490-8. PubMed ID: 16154350
[TBL] [Abstract][Full Text] [Related]
17. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
Itoh N; Sakaue S; Nakagawa H; Kurogochi M; Ohira H; Deguchi K; Nishimura S; Nishimura M
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1069-77. PubMed ID: 17666489
[TBL] [Abstract][Full Text] [Related]
18. A rapid sample preparation method for mass spectrometric characterization of N-linked glycans.
Yu YQ; Gilar M; Kaska J; Gebler JC
Rapid Commun Mass Spectrom; 2005; 19(16):2331-6. PubMed ID: 16041822
[TBL] [Abstract][Full Text] [Related]
19. [Congenital disorders of glycosylation].
Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion.
Furukawa J; Shinohara Y; Kuramoto H; Miura Y; Shimaoka H; Kurogochi M; Nakano M; Nishimura S
Anal Chem; 2008 Feb; 80(4):1094-101. PubMed ID: 18205388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
